The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / U.S. Health Spending Is Twice Other Countries’, with Worse Results

U.S. Health Spending Is Twice Other Countries’, with Worse Results

March 15, 2018 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—The U.S. spends about twice what other high-income nations do on healthcare, but has the lowest life expectancy and the highest infant mortality rates, a new study suggests.

You Might Also Like
  • Arthritis May Be Worse in Poor Countries, but Seem Worse in Rich Ones
  • CMS Says U.S. Health Spending to Rise 5.5% Per Year over Next Decade
  • U.S. Healthcare Spending to Climb 5.3 Percent in 2018

More doctor visits and hospital stays aren’t the problem. Americans use roughly the same amount of health services as people in other affluent nations, the study found. Instead, health spending may be higher in the U.S. because prices are steeper for drugs, medical devices, physician and nurse salaries and administrative costs to process medical claims, researchers reported March 13 online in JAMA.¹

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There’s no doubt that administrative complexity and higher drug prices both matter—as do higher prices for pretty much everything in U.S. healthcare,” says lead study author Irene Papanicolas of the London School of Economics and the Harvard T.H. Chan School of Public Health in Boston.

“These inefficiencies are likely the product of a number of factors including a reliance on fee-for-service reimbursement, the administrative complexity of the U.S. healthcare system and the lack of price transparency across the system,” Papanicolas says by email.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For the study, researchers examined international data from 2013 to 2016 comparing the U.S. with 10 other high-income countries: the U.K., Canada, Germany, Australia, Japan, Sweden, France, Denmark, the Netherlands and Switzerland.

In 2016, the U.S. spent 17.8% of its gross domestic product (GDP) on healthcare. Other countries’ spending ranged from a low of 9.6% of GDP in Australia to a high of 12.4% of GDP in Switzerland.

A large part of this was administrative costs, which accounted for 8% of GDP in the U.S., more than double the average of 3% of GDP.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

At the same time, the U.S. spent an average of $1,443 per person on drugs, compared with an average of $749 per person across all of the countries in the study.

U.S. spending was also higher for imaging and for many of the most common medical procedures, such as knee replacements, surgical cesarean births and surgeries to repair or unclog blood vessels.

If the U.S. did less imaging and fewer of 25 common procedures, and lowered prices and the number of procedures to levels in the Netherlands, it would translate into a savings of $137 billion, Dr. Ezekiel Emanuel of the Perelman School of Medicine at the University of Pennsylvania writes in an accompanying editorial.

“Regardless of what is done with the money, it would be more valuable than paying high prices for a large number of CT and MRI scans, up to a third of which may be deemed unnecessary and carry radiation risks, and many expensive, but not necessary surgical procedures,” Emanuel writes.

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: cost, cost of health care, Healthcare, spending, U.S. healthcare spending 2018

You Might Also Like:
  • Arthritis May Be Worse in Poor Countries, but Seem Worse in Rich Ones
  • CMS Says U.S. Health Spending to Rise 5.5% Per Year over Next Decade
  • U.S. Healthcare Spending to Climb 5.3 Percent in 2018
  • U.S. Health Agency Estimates 2015 Prescription Drug Spending Rose to $457 Billion

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.